Licochalcone A suppresses Sp1 expression with potential anti-myeloma activity

Cancer Commun (Lond). 2021 Nov;41(11):1239-1242. doi: 10.1002/cac2.12223. Epub 2021 Oct 19.

Authors

Hua Bai¹, Min Zhou¹, He Zhou², Qiaoyan Han², Han Xu³, Peipei Xu¹, Bing Chen¹

Affiliations

¹ Department of Hematology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu, 210008, P. R. China.
² Nanjing Drum Tower Hospital Clinical College of Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, 210008, P. R. China.
³ School of Medicine, Southeast University, Nanjing, Jiangsu, 210008, P. R. China.

No abstract available

Publication types

Letter
Comment

MeSH terms

Chalcones* / pharmacology
Chalcones* / therapeutic use
Humans
Multiple Myeloma* / drug therapy
Sp1 Transcription Factor

Substances

Chalcones
Sp1 Transcription Factor
SP1 protein, human
licochalcone A

Grants and funding

82000215/National Natural Science Foundation of China